Lee M. Ellis
Impact in
- Hepatology top 0.05%
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer Research top 0.02%
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Angiogenesis and VEGF in Cancer 136
- Oncology 172
- Colorectal Cancer Treatments and Studies 47
- Cancer Cells and Metastasis 30
- Cancer Treatment and Pharmacology 29
- Pancreatic and Hepatic Oncology Research 25
- Co-authors
- Daniel J. Hicklin (27 shared papers)C. Glenn Begley (1 shared paper)Fan Fan (79 shared papers)Wenbiao Liu (56 shared papers)Corazon D. Bucana (36 shared papers)Steven A. Curley (39 shared papers)Young Do Jung (28 shared papers)Jean‐Nicolas Vauthey (30 shared papers)
- Journals
- Journal of Clinical Oncology (28 papers)Clinical Cancer Research (20 papers)Cancer (19 papers)Cancer Research (14 papers)Annals of Surgical Oncology (14 papers)
- Partner nations
- United StatesJapanAustralia
In The Last Decade
Lee M. Ellis
359 papers receiving 37.7k citations
Lee M. Ellis's Hit Papers
Peers
Comparison fields: 5 of 209
- Hepatology 6.3k
- Cancer Research 9.6k
- Oncology 16.7k
- Molecular Biology 17.6k
- Pulmonary and Respiratory Medicine 6.5k
Countries citing papers authored by Lee M. Ellis
This map shows the geographic impact of Lee M. Ellis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lee M. Ellis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lee M. Ellis more than expected).
Fields of papers citing papers by Lee M. Ellis
This network shows the impact of papers produced by Lee M. Ellis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lee M. Ellis. The network helps show where Lee M. Ellis may publish in the future.
Co-authors
The 25 scholars most cited alongside Lee M. Ellis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 361 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis Hit paper breakdown → | 2004 | 2378 |
| 2 | Raise standards for preclinical cancer research Hit paper breakdown → | 2012 | 1761 |
| 3 | VEGF-targeted therapy: mechanisms of anti-tumour activity Hit paper breakdown → | 2008 | 1344 |
| 4 | Recurrence and Outcomes Following Hepatic Resection, Radiofrequency Ablation, and Combined Resection/Ablation for Colorectal Liver Metastases Hit paper breakdown → | 2004 | 1299 |
| 5 | Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Hit paper breakdown → | 1995 | 1095 |
| 6 | Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis Hit paper breakdown → | 2002 | 1019 |
| 7 | Radiofrequency Ablation of Unresectable Primary and Metastatic Hepatic Malignancies Hit paper breakdown → | 1999 | 856 |
| 8 | Insulin-like Growth Factor 1 Induces Hypoxia-inducible Factor 1-mediated Vascular Endothelial Growth Factor Expression, Which is Dependent on MAP Kinase and Phosphatidylinositol 3-Kinase Signaling in Colon Cancer Cells Hit paper breakdown → | 2002 | 684 |
| 9 | Antiangiogenic therapy in oncology: current status and future directions Hit paper breakdown → | 2016 | 644 |
| 10 | 2009 | 465 | |
| 11 | 2006 | 442 | |
| 12 | 2008 | 430 | |
| 13 | 2002 | 376 | |
| 14 | 2009 | 376 | |
| 15 | Disparity of Race Reporting and Representation in Clinical Trials Leading to Cancer Drug Approvals From 2008 to 2018 Hit paper breakdown → | 2019 | 365 |
| 16 | 2013 | 347 | |
| 17 | 2011 | 328 | |
| 18 | 2005 | 323 | |
| 19 | Enhanced antitumor activity of anti-epidermal growth factor receptor monoclonal antibody IMC-C225 in combination with irinotecan (CPT-11) against human colorectal tumor xenografts. | 2002 | 302 |
| 20 | 2014 | 291 |
About Lee M. Ellis
Lee M. Ellis is a scholar working on Molecular Biology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Hepatology, having authored 361 papers that have together received 38.8k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (136 papers), Cancer, Hypoxia, and Metabolism (80 papers), Colorectal Cancer Treatments and Studies (47 papers), Hepatocellular Carcinoma Treatment and Prognosis (43 papers), Cancer Cells and Metastasis (30 papers), Cancer Treatment and Pharmacology (29 papers), Gastric Cancer Management and Outcomes (25 papers) and Pancreatic and Hepatic Oncology Research (25 papers). The work is most often cited by research in Hepatology (6.3k citations), Cancer Research (9.6k citations), Oncology (16.7k citations), Molecular Biology (17.6k citations) and Pulmonary and Respiratory Medicine (6.5k citations). Lee M. Ellis has collaborated with scholars based in United States, Japan and Australia. Frequent co-authors include Daniel J. Hicklin, C. Glenn Begley, Fan Fan, Wenbiao Liu, Corazon D. Bucana, Steven A. Curley, Young Do Jung, Jean‐Nicolas Vauthey, Karen R. Cleary and Yutaka Takahashi. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Cancer, Cancer Research and Annals of Surgical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.